In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Genzyme, J&J Manufacturing Troubles Highlight The Importance Of Quality Systems

Executive Summary

Experts say robust quality systems, if taken to heart, can play a key role in preventing and recovering from manufacturing failures like the ones that have struck Genzyme and Johnson & Johnson in recent months.
Advertisement

Related Content

Sanofi Pursues Genzyme, But For How Long?
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q3 2010
Sanofi Pursues Genzyme, But For How Long?
Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q3 2010
J&J/DePuy Recalls ASR Hip Systems - Effort Could Cost $1.2 Bil.
J&J/DePuy Recalls ASR Hip Systems - Effort Could Cost $1.2 Bil.
Genzyme's Manufacturing Problems
Genzyme's Manufacturing Problems

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003540

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel